Your browser doesn't support javascript.
loading
Clonal heterogeneity as a driver of disease variability in the evolution of myeloproliferative neoplasms.
Prick, Janine; de Haan, Gerald; Green, Anthony R; Kent, David G.
Affiliation
  • Prick J; Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom; Laboratory of Ageing Biology and Stem Cells, European Research Institute for the Biology of Ageing, University Medical Center Groningen, University of Groningen, G
  • de Haan G; Laboratory of Ageing Biology and Stem Cells, European Research Institute for the Biology of Ageing, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
  • Green AR; Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom; Department of Haematology, University of Cambridge, Cambridge, United Kingdom; Department of Haematology, Addenbrooke's Hospital, Cambridge, United Kingdom.
  • Kent DG; Cambridge Institute for Medical Research and Wellcome Trust/MRC Stem Cell Institute, University of Cambridge, Cambridge, United Kingdom; Department of Haematology, University of Cambridge, Cambridge, United Kingdom; Department of Haematology, Addenbrooke's Hospital, Cambridge, United Kingdom. Electr
Exp Hematol ; 42(10): 841-51, 2014 Oct.
Article in En | MEDLINE | ID: mdl-25201757
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cells / Cell Transformation, Neoplastic / Clone Cells / Models, Genetic / Myeloproliferative Disorders Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Exp Hematol Year: 2014 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cells / Cell Transformation, Neoplastic / Clone Cells / Models, Genetic / Myeloproliferative Disorders Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Exp Hematol Year: 2014 Document type: Article